Clinical Trial Update: Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pulse radiotherapy to overcome metastatic immune system evasion in non-small cell lung cancer; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Pulse Radiotherapy

Snippet

Sponsor: Houda Bahig | Conditions: Non Small Cell Lung Cancer, Metastatic Lung Cancer | Phase 1 | Status: NOT_YET_RECRUITING